Search Results - Max S Topp

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemia by Anthony S. Stein, Richard A. Larson, Andre C. Schuh, William Stevenson, Ewa Lech-Maranda, Qui Tran, Zachary Zimmerman, William Kormany, Max S. Topp

    Published in Blood Advances (2018-07-01)
    Get full text
    Article


  2. 2

    Severe treatment-refractory T-cell-mediated immune skin toxicities observed with obinutuzumab/rituximab-atezo-pola in two patients with follicular lymphoma by Max S. Topp, Johannes Duell, Ana Maria Abajo Guijarro, Marielle Odin, Tina Nielsen, Anand Rajeswaran, Michael Wenger, Christelle Zundel, Aleksandra Bogucka-Fedorczuk, Tomasz Wrobel

    Published in Haematologica (2020-05-01)
    Get full text
    Article


  3. 3

    GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6 by Leo Rasche, Johannes Duell, Inês C. Castro, Valentina Dubljevic, Manik Chatterjee, Stefan Knop, Frank Hensel, Andreas Rosenwald, Hermann Einsele, Max S. Topp, Stephanie Brändlein

    Published in Haematologica (2015-03-01)
    Get full text
    Article


  4. 4

    Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia by Nicola Gökbuget, Gerhard Zugmaier, Matthias Klinger, Peter Kufer, Matthias Stelljes, Andreas Viardot, Heinz A. Horst, Svenja Neumann, Monika Brüggemann, Oliver G. Ottmann, Thomas Burmeister, Dorothea Wessiepe, Max S. Topp, Ralf Bargou

    Published in Haematologica (2017-04-01)
    Get full text
    Article


  5. 5

    Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemia by Nicola Gökbuget, Hagop M. Kantarjian, Monika Brüggemann, Anthony S. Stein, Ralf C. Bargou, Hervé Dombret, Adele K. Fielding, Leonard Heffner, Françoise Rigal-Huguet, Mark Litzow, Susan O'Brien, Gerhard Zugmaier, Shan Gao, Dirk Nagorsen, Stephen J. Forman, Max S. Topp

    Published in Blood Advances (2019-10-01)
    Get full text
    Article


  6. 6

    Molecular assessment of intratumoral immune cell subsets and potential mechanisms of resistance to odronextamab, a CD20×CD3 bispecific antibody, in patients with relapsed/refractor... by Dina M Flink, Se Jeong, Gavin Thurston, Rajat Bannerji, Vladimir Jankovic, Nathalie Fiaschi, Max S Topp, Jurriaan Brouwer-Visser, Raquel P Deering, Kamil J Cygan, Darius Scott, Lauren Boucher, Namita T Gupta, Suraj Gupta, Christina Adler, Johannes Duell, Ranjana H Advani, Aafia Chaudhry, Srikanth R Ambati

    Published in Journal for ImmunoTherapy of Cancer (2024-03-01)
    Get full text
    Article


  7. 7

    General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia by Nicola Gökbuget, Kristina Ihrig, Michael Stadler, Matthias Stelljes, Ahmet Elmaagacli, Michael Starck, Simon Raffel, Andrea Stoltefuss, Andreas Viardot, Karl-Anton Kreuzer, Daniela Heidenreich, Andrea Renzelmann, Ralph Wäsch, Max S. Topp, Barbara Ritter, Peter Reimer, Joachim Beck, Jörg Westermann, Knut Wendelin, Nael Alakel, Maher Hanoun, Hubert Serve, Dieter Hoelzer

    Published in Haematologica (2023-02-01)
    Get full text
    Article


  8. 8

    P367: LONG-TERM OUTCOMES OF ADULTS WITH RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH BREXUCABTAGENE AUTOLEUCEL IN ZUMA-3 BY AGE, PRIOR THERAPIES, AND SUB... by Bijal Shah, Ryan D. Cassaday, Jae H. Park, Roche Houot, Olalekan O. Oluwole, Aaron C. Logan, Nicolas Boissel, Thibaut Leguay, Michael R. Bishop, Max S. Topp, Kristen M. O’dwyer, Maria R. Baer, Gary J. Schiller, Mehrdad Abedi, Monique C. Minnema, Patrick Stiff, Lang Zhou, Tsveta Hadjivassileva, Rita Damico Khalid, Armin Ghobadi

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  9. 9

    Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene a... by Daniel J DeAngelo, Yi Lin, Roch Houot, Marion Subklewe, Petra C Schuberth, Michael R Bishop, Nicolas Boissel, Dimitrios Tzachanis, Jae H Park, Monique C Minnema, Thibaut Leguay, Mehrdad Abedi, Bijal D Shah, Ryan D Cassaday, Olalekan O Oluwole, Aaron C Logan, Max S Topp, Kristen M O'Dwyer, Martha L Arellano, Maria R Baer, Gary J Schiller, William G Wierda, Patrick J Stiff, Deepa Jeyakumar, Daqin Mao, Sabina Adhikary, Lang Zhou, Rita Damico Khalid, Armin Ghobadia

    Published in Journal for ImmunoTherapy of Cancer (2023-08-01)
    Get full text
    Article


Search Tools: